We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$666B
AUM Growth
+$8.72B
Cap. Flow
+$1.57B
Cap. Flow %
0.24%
Top 10 Hldgs %
22.76%
Holding
14,701
New
2,078
Increased
5,000
Reduced
5,363
Closed
2,191

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$775M
2
ABBV icon
AbbVie
ABBV
+$540M
3
DAL icon
Delta Air Lines
DAL
+$434M
4
LLY icon
Eli Lilly
LLY
+$433M
5
DXCM icon
DexCom
DXCM
+$433M

Sector Composition

Rank Sector Weight
1 Technology 4.89%
2 Healthcare 2.92%
3 Financials 2.71%
4 Consumer Discretionary 2.52%
5 Industrials 2.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPT
3201
PUT
Medical Properties Trust
MPT
$2.75B
$10.2M ﹤0.01%
2,042,300
-304,000
-13% -$1.58M
UUUU icon
3202
Energy Fuels
UUUU
$3.18B
$10.2M ﹤0.01%
701,966
-1,699,324
-71% -$28.8M
TMDX icon
3203
CALL
Transmedics
TMDX
$2.57B
$10.2M ﹤0.01%
83,900
-274,200
-77% -$34.4M
TSHA icon
3204
Taysha Gene Therapies
TSHA
$1.83B
$10.2M ﹤0.01%
1,854,855
+1,487,546
+405% +$7.22M
ATR icon
3205
AptarGroup
ATR
$8.69B
$10.2M ﹤0.01%
83,600
-64,364
-43% -$7.95M
BAX icon
3206
PUT
Baxter International
BAX
$14.3B
$10.2M ﹤0.01%
533,500
-64,700
-11% -$1.29M
MPWR icon
3207
Monolithic Power Systems
MPWR
$66.1B
$10.2M ﹤0.01%
11,229
-249,237
-96% -$240M
ITA icon
3208
CALL
iShares US Aerospace & Defense ETF
ITA
$14.7B
$10.2M ﹤0.01%
47,400
-28,300
-37% -$5.92M
HUBB icon
3209
CALL
Hubbell
HUBB
$27.1B
$10.2M ﹤0.01%
22,900
+7,000
+44% +$3.07M
VXX icon
3210
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$150M
$10.2M ﹤0.01%
383,650
-423,100
-52% -$13.8M
BCRX icon
3211
BioCryst Pharmaceuticals
BCRX
$2.26B
$10.1M ﹤0.01%
1,298,902
-60,980
-4% -$441K
NMRK icon
3212
Newmark Group
NMRK
$2.77B
$10.1M ﹤0.01%
584,037
-342,916
-37% -$6.01M
BYD icon
3213
CALL
Boyd Gaming
BYD
$6.26B
$10.1M ﹤0.01%
118,700
-45,500
-28% -$3.75M
CNS icon
3214
Cohen & Steers
CNS
$4.31B
$10.1M ﹤0.01%
160,987
+81,293
+102% +$5.29M
HII icon
3215
PUT
Huntington Ingalls Industries
HII
$12.7B
$10.1M ﹤0.01%
29,700
-43,100
-59% -$13.4M
WABC icon
3216
Westamerica Bancorp
WABC
$1.39B
$10.1M ﹤0.01%
210,400
+43,165
+26% +$2.07M
LAMR icon
3217
Lamar Advertising Co
LAMR
$15.9B
$10.1M ﹤0.01%
79,461
-25,163
-24% -$3.15M
RRC icon
3218
PUT
Range Resources
RRC
$9.05B
$10M ﹤0.01%
285,000
-18,400
-6% -$685K
FXY icon
3219
Invesco CurrencyShares Japanese Yen Trust
FXY
$451M
$10M ﹤0.01%
171,020
+146,271
+591% +$8.73M
GOLD
3220
Gold.com Inc
GOLD
$1.27B
$10M ﹤0.01%
294,419
-15,431
-5% -$441K
QSR icon
3221
PUT
Restaurant Brands International
QSR
$25.9B
$10M ﹤0.01%
146,600
-12,400
-8% -$854K
LYEL icon
3222
Lyell Immunopharma
LYEL
$331M
$9.99M ﹤0.01%
324,701
-14,790
-4% -$331K
UAMY icon
3223
CALL
United States Antimony
UAMY
$951M
$9.99M ﹤0.01%
1,990,800
+1,349,300
+210% +$10.6M
AEIS icon
3224
CALL
Advanced Energy
AEIS
$13.5B
$9.99M ﹤0.01%
47,700
-25,100
-34% -$5.11M
CRGY icon
3225
PUT
Crescent Energy
CRGY
$3.64B
$9.99M ﹤0.01%
1,190,330
+1,030,330
+644% +$9.05M

Similar funds

Citadel Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.

By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.

  • Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
  • Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
  • Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
  • Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
  • Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
  • Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
  • Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.